Ugur Sahin, CEO, and Özlem Türeci, CMO of BioNTech
July 26, 2022 01:43 PM EDT
Pharma
Coronavirus
Law

Pfiz­er and BioN­Tech hit back against Cure­Vac suit over Covid-19 vac­cine patents

Tyler Patchen

News Reporter

Af­ter its Covid-19 vac­cine can­di­date pe­tered out, Cure­Vac ear­li­er this month filed suit against BioN­Tech in Ger­man court, stat­ing that Cure­Vac should be com­pen­sat­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times